Clinical Trial Update: Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Meritup oral solution to decrease fatigue in metastatic breast cancer patients undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Meritup oral solution

Snippet

Sponsor: Chung Shan Medical University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN